Dimensional Fund Advisors LP Grows Position in Envista Holdings Corporation $NVST

Dimensional Fund Advisors LP raised its stake in shares of Envista Holdings Corporation (NYSE:NVST) by 4.0% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 9,537,874 shares of the company’s stock after purchasing an additional 367,363 shares during the period. Dimensional Fund Advisors LP owned 5.80% of Envista worth $194,284,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. GAMMA Investing LLC boosted its holdings in shares of Envista by 34.3% in the 3rd quarter. GAMMA Investing LLC now owns 2,498 shares of the company’s stock valued at $51,000 after purchasing an additional 638 shares during the last quarter. Claret Asset Management Corp grew its stake in shares of Envista by 6.5% during the 2nd quarter. Claret Asset Management Corp now owns 11,827 shares of the company’s stock valued at $231,000 after buying an additional 724 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in shares of Envista by 73.1% during the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company’s stock worth $44,000 after buying an additional 949 shares during the last quarter. Farther Finance Advisors LLC raised its position in shares of Envista by 317.6% in the 3rd quarter. Farther Finance Advisors LLC now owns 1,349 shares of the company’s stock worth $27,000 after buying an additional 1,026 shares during the period. Finally, Vanguard Personalized Indexing Management LLC raised its position in shares of Envista by 5.9% in the 3rd quarter. Vanguard Personalized Indexing Management LLC now owns 21,283 shares of the company’s stock worth $434,000 after buying an additional 1,183 shares during the period.

Envista Stock Down 4.0%

Shares of NYSE NVST opened at $26.82 on Monday. Envista Holdings Corporation has a 12-month low of $14.22 and a 12-month high of $30.42. The company has a market cap of $4.40 billion, a P/E ratio of 95.79, a P/E/G ratio of 1.83 and a beta of 0.95. The company has a current ratio of 2.38, a quick ratio of 2.04 and a debt-to-equity ratio of 0.47. The stock has a fifty day moving average price of $25.79 and a 200 day moving average price of $22.44.

Envista (NYSE:NVST) last issued its quarterly earnings data on Thursday, February 5th. The company reported $0.38 EPS for the quarter, topping analysts’ consensus estimates of $0.32 by $0.06. Envista had a return on equity of 6.54% and a net margin of 1.73%.During the same quarter in the previous year, the firm earned $0.24 EPS. The business’s revenue was up 15.0% on a year-over-year basis. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. Research analysts anticipate that Envista Holdings Corporation will post 1 EPS for the current fiscal year.

Insider Activity at Envista

In related news, SVP Mischa Reis sold 9,675 shares of the firm’s stock in a transaction dated Tuesday, February 10th. The stock was sold at an average price of $30.00, for a total transaction of $290,250.00. Following the sale, the senior vice president directly owned 32,382 shares in the company, valued at approximately $971,460. This trade represents a 23.00% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 0.66% of the company’s stock.

Analyst Ratings Changes

NVST has been the subject of a number of research reports. Morgan Stanley set a $19.00 price target on Envista in a research report on Friday, February 6th. Zacks Research upgraded Envista from a “hold” rating to a “strong-buy” rating in a report on Friday, February 6th. UBS Group lifted their price objective on Envista from $22.00 to $25.00 and gave the company a “neutral” rating in a research note on Tuesday, February 3rd. Barclays boosted their target price on Envista from $24.00 to $34.00 and gave the stock an “overweight” rating in a report on Wednesday, February 11th. Finally, Weiss Ratings raised shares of Envista from a “sell (d)” rating to a “hold (c-)” rating in a research report on Tuesday, February 17th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and seven have given a Hold rating to the company. Based on data from MarketBeat, Envista presently has a consensus rating of “Moderate Buy” and an average price target of $27.75.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.